Uetrecht Jack相关文献与解析，生知库 | 链接生命科学的每一步

Shinozawa, Tadahiro; Miyamoto, Kazumasa; Baker, Kevin S; Faber, Samantha C; Flores, Ramon; Uetrecht, Jack; von Hehn, Christian; Yukawa, Tomoya; Tohyama, Kimio; Kadali, Harisha; von Grotthuss, Marcin; Sudo, Yusuke; Smith, Erin N; Diogo, Dorothée; Zhu, Andy Z X; Dragan, Yvonne; Cebers, Gvido; Wagoner, Matthew P

肝损伤

毒理研究

发表日期：2025

文献求助收藏

Potential Involvement of Sulfotransferase in the Mechanism of Lamotrigine-induced Skin Rash

磺基转移酶可能参与拉莫三嗪诱发皮疹的机制

期刊:Chemical Research in Toxicology

影响因子:3.8

doi:10.1021/acs.chemrestox.3c00187

Cao, Yanshan; Bairam, Ahsan; Liu, Ming-Cheh; Uetrecht, Jack

发表日期：2023

文献求助收藏

Idiosyncratic Drug Reactions: A 35-Year Chemical Research in Toxicology Perspective

特异性药物反应：35 年化学毒理学研究视角

期刊:Chemical Research in Toxicology

影响因子:3.8

doi:10.1021/acs.chemrestox.2c00090

Uetrecht, Jack

发表日期：2022

文献求助收藏

Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges

特异性药物性肝损伤：机制和临床挑战

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms22062954

Jee, Alison; Sernoskie, Samantha Christine; Uetrecht, Jack

Testing Possible Risk Factors for Idiosyncratic Drug-Induced Liver Injury Using an Amodiaquine Mouse Model and Co-treatment with 1-Methyl-d-Tryptophan or Acetaminophen

利用阿莫地喹小鼠模型及1-甲基-D-色氨酸或对乙酰氨基酚联合治疗，检测特异性药物性肝损伤的潜在风险因素

期刊:ACS Omega

影响因子:4.3

doi:10.1021/acsomega.0c05352

Cho, Tiffany; Kok, Lie Yun; Uetrecht, Jack

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues

特异性药物性肝损伤（DILI）的机制：尚未解决的基本问题

期刊:Annals of Translational Medicine

影响因子:

doi:10.21037/atm-2020-ubih-05

Teschke, Rolf; Uetrecht, Jack

Mechanistic Studies of Idiosyncratic DILI: Clinical Implications

特异性药物性肝损伤的机制研究：临床意义

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2019.00837

Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI

编辑推荐：免疫耐受受损动物模型区分了曲格列酮/吡格列酮和托卡朋/恩他卡朋引起特发性免疫性肝损伤（IDILI）的潜在风险

期刊:Toxicological Sciences

影响因子:4.1

doi:10.1093/toxsci/kfx219

Mak, Alastair; Kato, Ryuji; Weston, Kyle; Hayes, Anthony; Uetrecht, Jack

Deferiprone-induced agranulocytosis: 20 years of clinical observations

去铁酮诱发的粒细胞缺乏症：20 年的临床观察

期刊:American Journal of Hematology

影响因子:9.9

doi:10.1002/ajh.24479

Tricta, Fernando; Uetrecht, Jack; Galanello, Renzo; Connelly, John; Rozova, Anna; Spino, Michael; Palmblad, Jan

Real-time imaging of oxidative and nitrosative stress in the liver of live animals for drug-toxicity testing

利用实时成像技术检测活体动物肝脏中的氧化应激和亚硝化应激，用于药物毒性测试

期刊:Nature Biotechnology

影响因子:41.7

doi:10.1038/nbt.2838

Shuhendler, Adam J; Pu, Kanyi; Cui, Lina; Uetrecht, Jack P; Rao, Jianghong

TAK-994 mechanistic investigation into drug-induced liver injury

TAK-994药物性肝损伤的机制研究

Potential Involvement of Sulfotransferase in the Mechanism of Lamotrigine-induced Skin Rash

磺基转移酶可能参与拉莫三嗪诱发皮疹的机制

Idiosyncratic Drug Reactions: A 35-Year Chemical Research in Toxicology Perspective

特异性药物反应：35 年化学毒理学研究视角

Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges

特异性药物性肝损伤：机制和临床挑战

Testing Possible Risk Factors for Idiosyncratic Drug-Induced Liver Injury Using an Amodiaquine Mouse Model and Co-treatment with 1-Methyl-d-Tryptophan or Acetaminophen

利用阿莫地喹小鼠模型及1-甲基-D-色氨酸或对乙酰氨基酚联合治疗，检测特异性药物性肝损伤的潜在风险因素

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues

特异性药物性肝损伤（DILI）的机制：尚未解决的基本问题

Mechanistic Studies of Idiosyncratic DILI: Clinical Implications

特异性药物性肝损伤的机制研究：临床意义

Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI

编辑推荐：免疫耐受受损动物模型区分了曲格列酮/吡格列酮和托卡朋/恩他卡朋引起特发性免疫性肝损伤（IDILI）的潜在风险

Deferiprone-induced agranulocytosis: 20 years of clinical observations

去铁酮诱发的粒细胞缺乏症：20 年的临床观察

Real-time imaging of oxidative and nitrosative stress in the liver of live animals for drug-toxicity testing

利用实时成像技术检测活体动物肝脏中的氧化应激和亚硝化应激，用于药物毒性测试